Preoperative latanoprost to prevent ocular hypertension after phacoemulsification and intraocular lens implantation.
J Cataract Refract Surg
; 27(11): 1792-5, 2001 Nov.
Article
em En
| MEDLINE
| ID: mdl-11709253
ABSTRACT
PURPOSE:
To evaluate the efficacy of latanoprost given 2 hours preoperatively to prevent ocular hypertension in the early period after phacoemulsification and posterior chamber intraocular lens (PC IOL) implantation.SETTING:
Departments of Ophthalmology, United Christian Hospital and Prince of Wales Hospital, Hong Kong, China.METHODS:
Sixty-four eyes of 64 patients with uncomplicated cataract having phacoemulsification with PC IOL implantation were included in this prospective randomized double-masked clinical trial. The eyes were randomly assigned to 1 of 2 groups application of latanoprost 0.005% 2 hours before surgery or no latanoprost (control). Intraocular pressure (IOP) was measured 3 and 24 hours postoperatively. The anterior chamber was examined for the level of cells and flare using a slitlamp biomicroscope. The level of significance was 5%.RESULTS:
The decrease in the mean IOP was not statistically significantly different between eyes receiving latanoprost 2 hours preoperatively and control eyes 3 hours (P =.843) and 24 hours (P =.721) postoperatively.CONCLUSION:
A single application of latanoprost given 2 hours before phacoemulsification and PC IOL implantation did not produce a statistically significant IOP-lowering effect when compared with a control group in the first 24 hours after surgery.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Prostaglandinas F Sintéticas
/
Hipertensão Ocular
/
Facoemulsificação
/
Implante de Lente Intraocular
/
Pressão Intraocular
/
Anti-Hipertensivos
Idioma:
En
Ano de publicação:
2001
Tipo de documento:
Article